…are limited liability company (the “GPLLC”). The initial managing members (the “Principals”) of the GPLLC are Philippe Chambon, Jeani Delagardelle, Ronald Hunt, Vijay Lathi and Liam Ratcliffe. To generate significant returns, principally th...
Philippe Chambon
Named in 3 passages across 2 documents.
Mentions of Philippe Chambon in the public Epstein records, with citations.
Being named in these documents is not an accusation or evidence of wrongdoing. This page reflects only what the public records literally contain, with citations to the original sources.
Where Philippe Chambon appears
3 total
s and one buy-out. Philippe is currently focused on New Leaf’s Information Convergence sector and late stage biopharmaceutical investments. Philippe is currently on the boards of directors of Treato, Truveris, Karos Pharmaceuticals, Princip...
…t $310 milion $450 million 1993 | 1995, 1997 | 1999 | 2001 | 2003 2005, 2007 2009 2011 2013 s @ 2 SENIOR TEAM Philippe Chambon, MD, Ph.D., (55), Managing Director, helped found New Leaf in 2005. Philippe joined Sprout in 1995 and since that...
NLV-III will be managed by the New Leaf team, which currently manages NLV-I, NLV-IL, and
IMAGES-007-HOUSE_OVERSIGHT_024022.txt
p.1
View source release ↗
Also named alongside
Want context across all of these passages at once?
Ask the documents about Philippe Chambon